(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with Carcinoma, Renal Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akporiaye, ET; Burch, PA; Frytak, S; Galanis, E; Kaur, JS; Lewis, B; Okuno, SH; Peethambaram, PP; Pitot, HC; Richardson, RL; Rubin, J; Spier, C; Unni, KK | 1 |
| Akporiaye, ET; Burch, P; Edmonson, J; Forscher, C; Galanis, E; Gonzalez, R; Hersh, EM; Lewis, BD; O'Driscoll, M; Rinehart, JJ; Rubin, J; Selk, L; Sobol, RE; Sondak, VK; Spier, C; Stopeck, AT; Unger, EC | 1 |
| Figlin, RA; Hoffman, DM | 1 |
| Kaushik, A | 1 |
1 review(s) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Leuvectin Vical Inc.
Topics: Animals; Carcinoma, Renal Cell; Clinical Trials as Topic; Cytotoxicity, Immunologic; Drug Carriers; Genetic Therapy; Genetic Vectors; Humans; Immunotherapy; In Vitro Techniques; Interleukin-2; Kidney Neoplasms; Lipids; Male; Phosphatidylethanolamines; Prostate-Specific Antigen; Prostatic Neoplasms; Quaternary Ammonium Compounds; Structure-Activity Relationship | 2001 |
3 trial(s) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.
Topics: Adult; Aged; Cancer Vaccines; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Female; Gene Expression Regulation; Gene Transfer Techniques; Genetic Therapy; Humans; Interleukin-2; Kidney Neoplasms; Lipids; Male; Middle Aged; Phosphatidylethanolamines; Plasmids; Quaternary Ammonium Compounds; Survival Analysis | 2004 |
Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.
Topics: Adult; Aged; Carcinoma, Renal Cell; CD8 Antigens; Dose-Response Relationship, Drug; Female; Gene Transfer Techniques; Genetic Therapy; Humans; Immunohistochemistry; Interleukin-2; Kidney Neoplasms; Lipids; Male; Melanoma; Middle Aged; Plasmids; Polymerase Chain Reaction; Quaternary Ammonium Compounds; Sarcoma; Skin Neoplasms | 1999 |
Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex.
Topics: Aged; Biopsy; Carcinoma, Renal Cell; Gene Transfer Techniques; Humans; Immunotherapy; Interleukin-2; Kidney Neoplasms; Lipids; Liver Neoplasms; Lung Neoplasms; Male; Plasmids; Quaternary Ammonium Compounds; Recombinant Proteins; Transgenes | 2000 |